Daniel Muñoz-Espín

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

EMBO molecular medicine

Journal of neuropathology and experimental neurology

The European respiratory journal

Molecular cancer therapeutics

University of Cambridge

Universidad Autonoma de Madrid Facultad de Ciencias (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Jan 09 2016

United Kingdom

Group Leader :: Oncology

Spanish National Cancer Research Centre May 01 2011 - Aug 30 2016

Spain

Postdoctoral Fellow

Education History

Universidad Autonoma de Madrid Facultad de Ciencias Oct 04 2002 - Dec 14 2006

Spain

PHD :: Biochemistry and Molecular Biology

Universidad Autonoma de Madrid Facultad de Ciencias Sep 15 1996 - Sep 27 2001

Spain

BSC :: Biology, Biochemistry and Molecular Biology

Publications

Bruno Henrique Rala de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, Susanne Crocamo Ventilari da Costa, Eliana Abdelhay, Daniel Muñoz-Espín
Targeting senescence as a therapeutic opportunity for triple-negative breast cancer. Molecular cancer therapeutics (2023)
Mary Denholm, Robert Campbell Rintoul, Daniel Muñoz-Espín
SARS-CoV-2-induced senescence as a potential therapeutic target. The European respiratory journal 60 (2) (2022)
Júlia Baixauli-Martín, Alicia Aliena-Valero, María Castelló-Ruiz, María C Burguete, Mikahela A López-Morales, Daniel Muñoz-Espín, Germán Torregrosa, Juan B Salom
Brain Cell Senescence: A New Therapeutic Target for the Acute Treatment of Ischemic Stroke. Journal of neuropathology and experimental neurology 81 (8) (2022)
Hui-Ling Ou, Reuben Hoffmann, Cristina González-López, Gary J Doherty, James E Korkola, Daniel Muñoz-Espín
Cellular senescence in cancer: from mechanisms to detection. Molecular oncology 15 (10) (2020)
Estela González-Gualda, Andrew G Baker, Ljiljana Fruk, Daniel Muñoz-Espín
A guide to assessing cellular senescence in vitro and in vivo. The FEBS journal 288 (1) (2020)
Estela González-Gualda, Marta Pàez-Ribes, Beatriz Lozano-Torres, David Macias, Joseph R Wilson, Cristina González-López, Hui-Ling Ou, Sofía Mirón-Barroso, Zhenguang Zhang, Araceli Lérida-Viso, Juan F Blandez, Andrea Bernardos, Félix Sancenón, Miguel Rovira, Ljiljana Fruk, Carla P Martins, Manuel Serrano, Gary J Doherty, Ramón Martínez-Máñez, Daniel Muñoz-Espín
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. Aging cell 19 (4) (2020)
Daniel Muñoz-Espín, Miguel Rovira, Irene Galiana, Cristina Giménez, Beatriz Lozano-Torres, Marta Paez-Ribes, Susana Llanos, Selim Chaib, Maribel Muñoz-Martín, Alvaro C Ucero, Guillermo Garaulet, Francisca Mulero, Stephen G Dann, Todd VanArsdale, David J Shields, Andrea Bernardos, José Ramón Murguía, Ramón Martínez-Máñez, Manuel Serrano
A versatile drug delivery system targeting senescent cells. EMBO molecular medicine 10 (9) (2019)
Marta Paez-Ribes, Estela González-Gualda, Gary J Doherty, Daniel Muñoz-Espín
Targeting senescent cells in translational medicine. EMBO molecular medicine 11 (12) (2019)

Daniel Muñoz-Espín.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Muñoz-Espín